Studies have demonstrated that over one-third of tumor types in the radiotherapy-sensitive group of solid tumors exhibit an enrichment of CD8 + T cells, M1 macrophages, and NK + cells (Grass et al., 2022). This evidence concerns the gene CD8A and neoplasm.